A Open-label, Drug-Drug Interaction With SB_MDZ in Healty Adult Subjects

Clinical trial NCT06846684 · COMPLETED

Trial details

NCT number: NCT06846684
Sponsor: SPARK Biopharma
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Drug Drug Interaction (DDI)

Start date: 2025-03-27
Primary completion: 2025-06-10
Enrollment: 12

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.